{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:57:34Z","timestamp":1778277454022,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.genhosppsych.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T03:03:57Z","timestamp":1371006237000},"page":"681.e13-681.e14","source":"Crossref","is-referenced-by-count":2,"title":["First manic episode in a patient with breast cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Elson","family":"Asevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0959-8049(01)00136-8","article-title":"Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment","volume":"37","author":"Harter","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9440(10)61180-7","article-title":"Breast cancer metastasis to the central nervous system","volume":"167","author":"Weil","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2001-0036","article-title":"The role of prolactin in mammary carcinoma","volume":"24","author":"Clevenger","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","article-title":"A review of the association between antipsychotic use and hyperprolactinaemia","volume":"22","author":"Bushe","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0030","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archpsyc.59.12.1147","article-title":"Dopamine antagonists and the development of breast cancer","volume":"59","author":"Wang","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/pon.3277","article-title":"Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population-based study","author":"Hung","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ajmg.b.31098","article-title":"Association analysis of PALB2 and BRCA2 in bipolar disorder and schizophrenia in a Scandinavian case\u2013control sample","volume":"153B","author":"Tesli","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0050","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2174\/138945010792006799","article-title":"Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics","volume":"11","author":"Goldberg","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.genhosppsych.2013.05.002_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1819.2012.02354.x","article-title":"Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages","volume":"66","author":"Mansur","year":"2012","journal-title":"Psychiatry Clin Neurosci"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834313001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834313001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T10:51:20Z","timestamp":1539600680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834313001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0163834313001436"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.05.002","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}